PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9833017-2	1997	To determine the impact of impaired AMP metabolism on its behavioural effects, AMP-induced hyperactivity, AMP discrimination and AMP self-administration were examined in male Wistar rats with or without pretreatment with the CYP2D1 inhibitors quinine and budipine.	Quinine	243-250	cytochrome P450, family 2, subfamily d, polypeptide 1	Rattus norvegicus	225-231	
9833017-3	1997	In vivo, quinine (20 mg/kg) and budipine (10 mg/kg) increased the plasma area under the curve of AMP 4-fold and 3.6-fold respectively, and decreased the plasma levels of 4-OH-AMP, 3-fold and 8.6-fold, confirming that the doses used suppressed CYP2D1 activity.	Quinine	9-16	cytochrome P450, family 2, subfamily d, polypeptide 1	Rattus norvegicus	243-249